Value-based payment: Not all insurers are on board
A physician researcher discusses why primary care physicians do not participate in value-based payment models.
Value-based payment: Or is it fee-for-service? Or both?
Value-based payment: Will it cover the cost of doing business?
Value-based payment: Sources and a summary
Value-based payment: An introduction to a study
GLP-1 RA drugs and primary care: What do physicians need to know?
Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.
How to navigate discussions with patients about what they see on social media
Richard W. Miller, MD, discusses the best ways to handle conversations about treatment options with patients who consume misinformation online.
How to ensure that patients are well-educated considering the influence of social media
Richard W. Miller, MD, discusses what physicians can do to ensure patient education in spite of misinformation available online.
The importance of shared decision-making when navigating social media misinformation
Richard W. Miller, MD, explains why shared decision-making is so important when navigating patient concerns rooted in social media misinformation.
How to manage a tense situation when a misinformed patient becomes frustrated
Richard W. Miller, MD, talks managing a situation when a misinformed patient becomes frustrated.
How to respond when a patient requests what they've seen online
Richard W. Miller, MD, discusses the proper response when a patient makes a misinformed request.
How do social media trends lead to unrealistic patient expectations about treatment options?
Richard W. Miller, MD, discusses how social media trends can result in misinformed patients.
Transforming “what if” to “what is” with the Veradigm Network
Our network connects providers, health plans, and life science companies to deliver seamless care that benefits everyone
GLP-1 RA antiobesity medications: Predictions for the future
A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.
GLP-1 RA antiobesity medications: Long-term safety
GLP-1 RA antiobesity medications: Learning about side effects, and managing them
GLP-1 RA antiobesity medications: Lifestyle changes needed too
GLP-1 RA antiobesity medications: Talking about cost
GLP-1 RA antiobesity medications: Patients’ No. 1 question
GLP-1 RA antiobesity medications: a new panacea?
GLP-1 RA antiobesity medications: an introduction
What everyone needs to know about the CDC's latest vaccine recommendations - and how to approach patient concerns
Jay W. Lee, MD, MPH, FAAFP, explains the CDC's recently updated recommendations for COVID-19 and pneumococcal vaccinations and explains how to best handle patient concerns and misinformation.
The importance of maintaining the physician-patient relationship
Jay W. Lee, MD, MPH, FAAFP, explains the importance of consistency and maintaining a relationship with a patient over time.
Why should patients seek vaccinations from family physicians over retail pharmacies?
Jay W. Lee, MD, MPH, FAAFP, advises family physicians to continue offering vaccines, explaining the benefits compared to alternatives.
Addressing vaccine hesitancy and misinformation
Jay W. Lee, MD, MPH, FAAFP, shares how physicians should properly approach patient concerns regarding vaccines.
Approaching the vaccine conversation after the COVID-19 pandemic
Jay W. Lee, MD, MPH, FAAFP, explains how physicians should approach the vaccine conversation in the wake of the COVID-19 pandemic.
Starting the vaccine conversation as respiratory illness season ramps up
Jay W. Lee, MD, MPH, FAAFP, talks about appropriate and effective ways of initiating the vaccine conversation during respiratory illness season.
The CDC's latest recommendations for COVID-19 and pneumococcal vaccines
Jay W. Lee, MD, MPH, FAAFP, discusses the CDC's latest guidelines regarding the COVID-19 vaccine and expanded recommendations for pneumococcal vaccines.
Everything you need to know about the latest change to MOC - and what might be next
ABIM eliminated the 2-year points requirement. Here's what you need to know about that - and what else might be changing.
How the most recent MOC change is a reflection of new leadership at the organization
ABIM has a new leader and the most recent change - the removal of the 2-year points requirement - is a reflection of the new direction the organization is headed.
